Data / Form D filings / Evergreen Theragnostics Inc.
Evergreen Theragnostics Inc.: Form D filings
Evergreen Theragnostics Inc., a pharmaceuticals company in Springfield, NJ, filed 2 Form D notices with the SEC between 2020 and 2023. The latest, on August 18, 2023, reports $15.5 million sold of a $15.5 million offering to 58 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 27 COMMERCE ST, Springfield, NJ, 07081
- Phone
- (917) 319-1920
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2019
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1816034
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 18, 2023 | New notice | $15,461,652 | $15,461,652 | 58 | Dec 15, 2022 | sec.gov | |
| Jun 30, 2020 | New notice | $25,000,000 | $19,451,937 | $5,548,063 | 76 | Apr 27, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Serge Lyashchenko | Director | |
| Sharon Roded | Director | |
| Enrico De Maria | Director | |
| Gerard Ber | Director | |
| James Cook | Executive Officer, Director |
Other pharmaceuticals companies in New Jersey that filed recently
- Grace Therapeutics, Inc. $10 million · Aug 11, 2026
Every Form D from the week of Aug 14, 2023 · All recent filings in New Jersey · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Evergreen Theragnostics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.